European framework for tuberculosis control and elimination in countries with a low incidence
Top Cited Papers
- 1 April 2002
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 19 (4) , 765-775
- https://doi.org/10.1183/09031936.02.00261402
Abstract
As countries approach the elimination phase of tuberculosis, specific problems and challenges emerge, due to the steadily declining incidence in the native population, the gradually increasing importance of the importation of latent tuberculosis infection and tuberculosis from other countries and the emergence of groups at particularly high risk of tuberculosis. Therefore, a Working Group of the World Health Organization (WHO), the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Royal Netherlands Tuberculosis Association (KNCV) have developed a new framework for low incidence countries based on concepts and definitions consistent with those of previous recommendations from WHO/IUATLD Working Groups. In low-incidence countries, a broader spectrum of interventions is available and feasible, including: 1) a general approach to tuberculosis which ensures rapid detection and treatment of all the cases and prevention of unnecessary deaths; 2) an overall control strategy aimed at reducing the incidence of tuberculosis infection (risk-group management and prevention of transmission of infection in institutional settings) and 3) a tuberculosis elimination strategy aimed at reducing the prevalence of tuberculosis infection (outbreak management and provision of preventive therapy for specified groups and individuals). Government and private sector commitment towards elimination, effective case detection among symptomatic individuals together with active case finding in special groups, standard treatment of disease and infection, access to tuberculosis diagnostic and treatment services, prevention (e.g. through screening and bacille Calmette-Guéria immunization in specified groups), surveillance and treatment outcome monitoring are prerequisites to implementing the policy package recommended in this new framework document.Keywords
This publication has 27 references indexed in Scilit:
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- Risk ofMycobacterium tuberculosisTransmission in a Low-Incidence Country Due to Immigration from High-Incidence AreasJournal of Clinical Microbiology, 2001
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Prospective multicentre study on the evaluation of antituberculosis treatment results in Italy: comparison of the culture- versus the smear-based methodsEuropean Respiratory Journal, 1999
- Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patientsEuropean Respiratory Journal, 1998
- Assessment of worldwide tuberculosis controlThe Lancet, 1997
- Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis casesEuropean Respiratory Journal, 1996
- Why do our patients die of active tuberculosis in the era of effective therapy?Tubercle and Lung Disease, 1994
- Tuberculosis control in Europe and international migrationEuropean Respiratory Journal, 1994
- The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in TuberculosisNew England Journal of Medicine, 1994